King’s College research on the effects of cannabinoids on lung inflammation

The primary purpose of this study was to investigate the anti-inflammatory effects of two of the non-psychotropic cannabinoids, cannabidiol (CBD) and Cannabigerol (CBG) alone and in combination, in a model of pulmonary inflammation. The results of the work suggest that the cannabinoids CBD and CBG in combination have significant anti-inflammatory activity in the lung.

The Sativa Group sponsored the study as part  of its research agreement. The full research paper which can be found at;

https://www.sciencedirect.com/science/article/abs/pii/S1094553921000596

 

 

 



Goodbody is a trading name of Goodbody Botanicals Ltd a member of the Goodbody Health Group.

Goodbody products are not intended to treat, diagnose, cure or prevent any disease. The information and products presented on this site are not intended for medical use nor do they make any medical claims. Always seek the advice of your physician or another qualified healthcare provider for any questions you have regarding a medical condition, and before undertaking any diet, exercise or other health related program.

Copyright © 2021 Goodbody Botanicals Ltd

Company

Goodbody Botanicals Ltd
The Blue Building
Stubbs Lane
Beckington
BA11 6TE


* For further details about the Goodbody Health Group please click here